SSTR2 and neoplasm: In conclusion,our data shows that the engineered dye FNIR-Tagcan produce an SSTR2-targeted FGS agent with superior tumor specificity.Clinical application of our agent may enable the detection and removalof multifocal small bowel NETs and nodal disease that may otherwisebe missed with standard surgical techniques.